VCYT
VCYT
NASDAQ · Biotechnology

Veracyte Inc

$31.84
-0.94 (-2.87%)
As of Mar 22, 9:59 PM ET ·
Financial Highlights (FY 2026)
Revenue
514.33M
Net Income
65.99M
Gross Margin
70.1%
Profit Margin
12.8%
Rev Growth
+20.4%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 70.1% 70.1% 67.1% 67.1%
Operating Margin 11.2% 10.1% -0.5% -0.5%
Profit Margin 12.8% 12.2% -0.4% -0.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 514.33M 427.29M 507.99M 466.85M
Gross Profit 360.54M 299.53M 340.77M 313.18M
Operating Income 57.45M 42.96M -2,427,180 -2,364,906
Net Income 65.99M 49.34M -2,027,984 -2,410,114
Gross Margin 70.1% 70.1% 67.1% 67.1%
Operating Margin 11.2% 10.1% -0.5% -0.5%
Profit Margin 12.8% 12.2% -0.4% -0.5%
Rev Growth +20.4% +20.4% +16.6% +7.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 875.10M 761.72M
Total Equity 1.67B 1.94B
D/E Ratio 0.52 0.39
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 59.09M 46.64M -2,983,128 -2,794,572
Free Cash Flow -1,866,923 -2,624,091